Sponsor:
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Code:
NCT06965426
Conditions
Macular Degenerative Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Brief summary:
Conditions
Macular Degenerative Disease
Study ID
NCT06965426
Start date
Jun 1, 2025
Status verified date
Aug, 2026
Completion date
Dec 29, 2026
Anticipated
Primary completion date
Oct 29, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Prevention
Arms
active comparator: MacuHealth Supplementation
placebo comparator: Placebo
Interventions
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Primary outcome measure
Central contacts
Locations
Vision Source
Recruiting
Kansas City, Missouri, United States, 64111
Contacts
Sponsor
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Last update posted
Sep 1, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Insight Eyecare Specialties, Inc. dba Vision Source Eyecare, on 2026-09-01.